Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Collins

Showing results (201-210 of 205) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 205 results.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analogM I Damaj, W Glassco, M J Marks, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 7, 2001
UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomesC G Sharples, S Kaiser, L Soliakov, et al.
Journal of Neurochemistry|January 9, 2001
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatumS R Grady, N M Meinerz, J Cao, et al.
Neuron|February 22, 2001
The role of RNA editing of kainate receptors in synaptic plasticity and seizuresB Vissel, G A Royle, B R Christie, et al.
ESMO Gastrointestinal Oncology|October 1, 2025
Pharmacological advances in cannabinoid-based therapies for pancreatic cancer: preclinical efficacy of CCL-106 and its epimersK P Ray, W Cruces, Y Mzannar, et al.
Pageof 21

Showing results (201-210 of 205) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 205 results.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 1997
Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analogM I Damaj, W Glassco, M J Marks, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 7, 2001
UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomesC G Sharples, S Kaiser, L Soliakov, et al.
Journal of Neurochemistry|January 9, 2001
Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatumS R Grady, N M Meinerz, J Cao, et al.
Neuron|February 22, 2001
The role of RNA editing of kainate receptors in synaptic plasticity and seizuresB Vissel, G A Royle, B R Christie, et al.
ESMO Gastrointestinal Oncology|October 1, 2025
Pharmacological advances in cannabinoid-based therapies for pancreatic cancer: preclinical efficacy of CCL-106 and its epimersK P Ray, W Cruces, Y Mzannar, et al.
Pageof 21